News and views from the world of clinical oncology and hematology ascopost.com James O. Armitage, MD, FASCO Editor-in-Chief ASCOPost.com @ASCOPost Send your comments to [email protected]MORE IN THIS ISSUE WITH ALL the advances in oncology care over the past decade, the most important contribution to high-quality care remains the personal connection between oncologist and patient, said Monica M. Bertagnolli, MD, FACS, FASCO, ASCO President-Elect, who will take the reins as ASCO’s 55th President during the ASCO Annual Meeting, June 1–5, 2018, in Chicago. An active ASCO member since 1995, serving on the ASCO Board of Directors, the Cancer Prevention Committee, and the Strategic Planning Com- mittee, Dr. Bertagnolli will be the first ASCO President to serve a 4-year term on the ASCO Board, serving her first year as President-Elect; second as President and Chair of the Board; third as Chair of the Board; and fourth as Past President. The extra time, she said, gives her a unique opportunity to see the goal of her THE NONINFERIORITY phase III Persephone trial could shake up the standard of care for ad- juvant trastuzumab (Herceptin), showing that patients with early-stage HER2-positive breast cancer derived as much benefit from 6 months of trastuzumab as 12 months, according to re- search from the United Kingdom to be reported at the 2018 ASCO Annual Meeting.1 “The first results of Persephone demon- strate that 6 months of adjuvant trastuzumab is noninferior to 12 months. Given the cardiac and other toxicities during months 7 to 12 of treatment, our results would support a reduc- tion of standard trastuzumab duration to 6 months,” said HelenaMargaret Earl, MBBS, PhD, of the University of Cambridge and the National Institute for Health Research Cambridge Biomedical Research Cen- ter in the United Kingdom. Interest in the study was high during a press briefing in advance of the ASCO meeting. The press conference moderators maintained that longer follow-up and a closer look at the data are needed before oncologists change practice. “Personally, I find the results quite compel- ling, and I think they will likely signal a shift in the U.S. oncology community toward shorter duration of therapy,” said Richard L. Schilsky, MD, FACP, FASCO, Chief Medical Officer for ASCO. But he thought a more detailed analysis is warranted, especially to identify women who would VOLUME 9 | ISSUE 9 | MAY 25, 2018 Special Focus on CAR T-Cell Therapy pp. 10, 25, 30, 44–52, 53, 104–107 Managing Immune-Related Adverse Events pp. 23, 38–40 Adolescent and Young Adult Oncology pp. 84–86 ASCO ANNUAL MEETING For Adjuvant Trastuzumab, 6 Months Is Noninferior to 12 Months by CAROLINE HELWICK GOALS AND CHALLENGES ASCO’s Incoming President Sets Her Goals for the Next Year A Conversation With Monica M. Bertagnolli, MD, FACS, FASCO by JO CAVALLO CONTINUED ON P. 121 CONTINUED ON P. 4 ONCOLOGY MEETING NEWS ASCO Annual Meeting................1, 3–5, 92 Miami Breast Cancer Conference............ 6 Society of Surgical Oncology ................ 12 NCCN Annual Conference ......... 14–16, 22 AACR Annual Meeting...................... 24, 25 OBESITY AND CANCER............................ 33 ASCO CLINICAL GUIDELINES..... 38, 107, 108 CAR T-CELL COST AND VALUE .........44–52 PROSTATE CANCER: THE PRECISION TRIAL...................... 60, 62 DIRECT FROM ASCO...........................64–67 LIVING A FULL LIFE.............................96–97 ASCO AFFILIATE, TENNESSEE ONCOLOGY........................108 Serving as ASCO President Is One of the Best Jobs in the World by BRUCE E. JOHNSON, MD, FASCO “Engineering T cells is a way to put the immune system on steroids and boost it to fight not just cancer but other chronic diseases as well.” —CARL JUNE, MD SEE PP. 44–52 CONTINUED ON P. 130 Monica M. Bertagnolli, MD, FACS, FASCO Helena Margaret Earl, MBBS, PhD Dr. Johnson is President of ASCO; Chief Clinical Research Officer and Institute Physician at Dana-Farber Cancer Institute; and Professor of Medicine at Harvard Med- ical School. In 2008, he was awarded the Translational Research Professorship from the Conquer Cancer Foundation of ASCO. THE OPPORTUNITY to serve as ASCO President is the greatest honor of my professional career. It has been a pleasure and a highly rewarding experience to interact with our members and members of ASCO’s Board, executive leader- ship, and professional staff during my tenure. The year has allowed me to work on advancing the bene- fits of precision medicine for our patients, which is consistent with the theme of my Presidential year, “Delivering Discoveries: Expanding the Reach of Precision Medicine.” My Presidential year has also provid- ed me with the chance to advocate for ASCO’s Effective January 2019 2019 RATE CARD
Transcript
News and views from the world of clinical oncology and hematology
W I T H A L L the advances in oncology care over the past decade, the most important contribution to high-quality care remains the personal connection between oncologist and patient, said Monica M. Bertagnolli, MD, FACS, FASCO, ASCO President-Elect, who will take the reins as ASCO’s 55th President during the ASCO Annual Meeting, June 1–5, 2018, in Chicago. An active ASCO member since 1995, serving on the ASCO Board of Directors, the Cancer Prevention Committee, and the Strategic Planning Com-mittee, Dr. Bertagnolli will be the first ASCO President to serve a 4-year term on the ASCO Board, serving her first year as President-Elect; second as President and Chair of
the Board; third as Chair of the Board; and fourth as Past President. The extra time, she said, gives her a unique opportunity to see the goal of her
T H E N O N I N F E R I O R I T Y phase III Persephone trial could shake up the standard of care for ad-juvant trastuzumab (Herceptin), showing that patients with early-stage HER2-positive breast cancer derived as much benefit from 6 months of trastuzumab as 12 months, according to re-search from the United Kingdom to be reported at the 2018 ASCO Annual Meeting.1
“The first results of Persephone demon-strate that 6 months of adjuvant trastuzumab is noninferior to 12 months. Given the cardiac and other toxicities during months 7 to 12 of treatment, our results would support a reduc-tion of standard trastuzumab duration to 6 months,” said Helena Margaret Earl, MBBS, PhD, of the University of
Cambridge and the National Institute for Health Research Cambridge Biomedical Research Cen-ter in the United Kingdom.
Interest in the study was high during a press briefing in advance of the ASCO meeting. The press conference moderators maintained that longer follow-up and a closer look at the data are needed before oncologists change practice.
“Personally, I find the results quite compel-ling, and I think they will likely signal a shift in the U.S. oncology community toward shorter duration of therapy,” said Richard L. Schilsky, MD, FACP, FASCO, Chief Medical Officer for
ASCO. But he thought a more detailed analysis is warranted, especially to identify women who would
Serving as ASCO President Is One of the Best Jobs in the Worldb y BRUCE E. JOHNSON, MD, FASCO
“Engineering T cells is a way to put the
immune system on steroids and boost it
to fight not just cancer but other chronic diseases as well.”
— C A R L J U N E , M D SEE PP. 44–52
CONTINUED ON P. 130
Monica M. Bertagnolli, MD, FACS, FASCO
Helena Margaret Earl, MBBS, PhD
Dr. Johnson is President of ASCO; Chief Clinical Research Officer and Institute Physician at Dana-Farber Cancer Institute; and Professor of Medicine at Harvard Med-ical School. In 2008, he was awarded the Translational Research Professorship from the Conquer Cancer Foundation of ASCO.
T H E O P P O R T U N I T Y to serve as ASCO President is the greatest honor of my professional career. It has been a pleasure and a highly rewarding experience to interact with our members and members of ASCO’s Board, executive leader-ship, and professional staff during my tenure. The year has allowed me to work on advancing the bene-fits of precision medicine for our patients, which is consistent with the theme of my Presidential year, “Delivering Discoveries: Expanding the Reach of Precision Medicine.”
My Presidential year has also provid-ed me with the chance to advocate for ASCO’s
Effective January 2019
2019 RATE CARD
2
201
9 R
ate
Ca
rd •
Th
e A
SCO
Po
st
Print Advertising OpportunitiesGeneral Information — EditorialEstablished – 2010
Mission StatementThe ASCO Post, in partnership with the American Society of Clinical Oncology (ASCO), communicates news of evidence-based multidisciplinary cancer care to a broad audience of oncology professionals and ASCO members.
AboutThe ASCO Post is a newspaper available in print and digitally. Each issue of The ASCO Post features highly validated coverage of clinical cancer research, policy news, patient care, clinical practice issues, and thoughtful commentary by leaders in the field of clinical oncology.
EditorialThe ASCO Post delivers timely and unbiased reports on major oncology meetings worldwide, including ASCO’s Annual Meeting, and regional and thematic symposia. Additionally, The ASCO Post provides readers with important summaries of evidence-based research from peer-reviewed clinical journals (fully sourced with links to original reports); notable research, data, and literature with application in the clinic, including cost considerations/implications; and perspective pieces from ASCO’s membership, with viewpoints on developments in oncology, advances in immunotherapy, value in cancer care, and expert opinion on the state and economics of cancer care.
The ASCO Post publishes news from the National Institutes of Health, the National Cancer Institute, and the U.S. Food and Drug Administration. Further, the publication covers developments in health-care reform and the impact on oncology practice; news from the pharmaceutical and manufacturing industries; information from cancer.gov on clinical trials; issues pertinent to community oncology practice, careers in oncology, and oncology trends; meetings calendar; and ASCO member milestones (relocations, new appointments, announcements, etc).
TABLE OF CONTENTSPrint Advertising Opportunities ..................................................................................................2-3
The ASCO Post Evening News ..............................................................................................11
E-TOC – The ASCO Post ..........................................................................................................12
The ASCO Post Almanacs and Meeting Highlights ............................................................ 13
Digital Specifications.....................................................................................................................14
Additional Terms and Conditions ................................................................................................15
Contact Us ...........................................................................................................................16
3
2019 R
ate
Ca
rd •
The
ASC
O P
ost
About ASCOHistory, Mission, and Vision:• Founded 1964• Apporoximately 45,000 members in more than 150
countries• Largest clinical oncology scientific meeting in the world;
~40,000 attendees annually• Mission: Conquering cancer through research, education,
and promotion of the highest-quality patient care• Vision: A world where cancer is prevented or cured, and
every survivor is healthy
FrequencyTwenty-four issues including one annual special issue. Regular issues will be 2 ×/month for all months February-December with issue dates on the 10th and 25th of the month. Only one issue in January dated January 25th. The Narratives in Oncology Special Issue, dated June 3, 2019 will be mailed independently and also will be distributed at the ASCO Annual Meeting.
24 issue dates:January 25 • February 10 • February 25 • March 10 March 25 • April 10 • April 25 • May 10 • May 25 June 3* • June 10 • June 25 • July 10 • July 25 August 10 • August 25 • September 10 • September 25 October 10 • October 25 • November 10 • November 25 December 10 • December 25 *Special Issue: Narratives in Oncology
Effective Date and DiscountsRates effective as of January 2019. Rate changes will be issued with 90-day written notice. Fifteen percent (15%) agency discount of gross billings on space, color, cover, and preferred position charges. Payment terms are net 30 days of invoice date. Pre-payment discounts are available, contact publisher for more information.
Earned Rates: Earned rates are given to advertisers (parent companies and their subsidiaries) based on the total number of pages placed within a 12-month period. A spread counts as two pages regardless of its size (king or A-size pages).
Advertising PoliciesPlacement of Advertising: Interspersed within articles. Placement location is at the discretion of Harborside.
Circulation — 28,068A subscription to The ASCO Post is sent to US-based ASCO members, including oncologists, hematologists, hematologists/oncologists, surgical oncologists, gynecologic oncologists, pediatric oncologists, radiation oncologists, as well as all other domestic nonmember medical oncologists, hematologists, hematologists/oncologists.
Additionally, a subscription is also available as a benefit of membership to all US-based ASCO and Advanced Practitioner Society of Hematology and Oncology (APSHO) nurse practitioners, physician assistants and oncology pharmacists.
Total 28,068*Includes dermatologists, musculoskeletal oncologists, lab personnel, biostat-isticians, allied health care professionals, and other field-related personnel.
ASCO Member Profile: Board Certification of US–based ASCO Members
Medical Oncology 7,766
Internal Medicine 8,128
Hematology 5,711
Radiation Oncology 909
Surgery (incl. Surgical Oncology) 721
Other 2,639
Pediatrics (incl. Pediatric Oncology) 792
Gynecologic Oncology 329
Oncology Pharmacy 486
Oncology Nursing 313
Pathology 217
Urology 143
Neurology 131
Members may choose more than one category and not all give a response—updated June 2018. Does not include 3,980 Fellowship specialties (including 1,482 Med/Onc and Hem/Onc and 927 in Internal Medicine).
4
201
9 R
ate
Ca
rd •
Th
e A
SCO
Po
st Print Advertising Rates
Insert RatesIsland Size Insert
FREQUENCY 2-PG 4-PG 6-PG 8-PG
1 × $9,955 $19,310 $28,720 $38,005
6 × $9,865 $19,130 $28,450 $37,645
12 × $9,795 $18,990 $28,240 $37,365
24 × $9,705 $18,810 $27,970 $37,005
36 × $9,615 $18,630 $27,700 $36,645
48 × $9,535 $18,470 $27,460 $36,325
60 × $9,475 $18,350 $27,280 $36,085
72 × $9,385 $18,170 $27,010 $35,725
96 × $9,285 $17,970 $26,710 $35,325
120 × $9,225 $17,850 $26,530 $35,085
144 × $9,125 $17,650 $26,230 $34,685
170 × $9,035 $17,470 $25,960 $34,325
194 × $8,975 $17,350 $25,780 $34,085
216 × $8,905 $17,210 $25,570 $33,805
242 × $8,805 $17,010 $25,270 $33,405
268 × $8,735 $16,870 $25,060 $33,125
304 × $8,645 $16,690 $24,790 $32,765
340 × $8,485 $16,370 $24,310 $32,125
376 × $8,415 $16,230 $24,100 $31,845
King Size Insert
FREQUENCY 2-PG 4-PG 6-PG 8-PG
1 × $12,615 $24,630 $36,700 $48,645
6 × $12,495 $24,390 $36,340 $48,165
12 × $12,395 $24,190 $36,040 $47,765
24 × $12,265 $23,930 $35,650 $47,245
36 × $12,155 $23,710 $35,320 $46,805
48 × $12,035 $23,470 $34,960 $46,325
60 × $11,965 $23,330 $34,750 $46,045
72 × $11,875 $23,150 $34,480 $45,685
96 × $11,825 $23,050 $34,330 $45,485
120 × $11,745 $22,890 $34,090 $45,165
144 × $11,675 $22,750 $33,880 $44,885
170 × $11,575 $22,550 $33,580 $44,485
194 × $11,495 $22,390 $33,340 $44,165
216 × $11,425 $22,250 $33,130 $43,885
242 × $11,325 $22,050 $32,830 $43,485
268 × $11,265 $21,930 $32,650 $43,245
304 × $11,165 $21,730 $32,350 $42,845
340 × $11,015 $21,430 $31,900 $42,245
376 × $10,915 $21,230 $31,600 $41,845
Advertising Rates – Run of BookBlack and White
FREQUENCY KING-PG 3/4-PG ISLAND 1/2-PG 1/4-PG
1 × $5,945 $5,515 $4,615 $3,215
6 × $5,885 $5,480 $4,570 $3,195
12 × $5,835 $5,435 $4,535 $3,165
24 × $5,770 $5,390 $4,490 $3,150
36 × $5,715 $5,355 $4,445 $3,135
48 × $5,655 $5,315 $4,405 $3,120
60 × $5,620 $5,275 $4,375 $3,090
72 × $5,575 $5,230 $4,330 $3,070
96 × $5,550 $5,190 $4,280 $3,055
120 × $5,510 $5,150 $4,250 $3,025
144 × $5,475 $5,105 $4,200 $3,010
170 × $5,425 $5,070 $4,155 $2,990
194 × $5,385 $5,030 $4,125 $2,965
216 × $5,350 $4,980 $4,090 $2,950
242 × $5,300 $4,945 $4,040 $2,935
268 × $5,270 $4,910 $4,005 $2,910
304 × $5,220 $4,860 $3,960 $2,890
340 × $5,145 $4,785 $3,880 $2,840
376 × $5,095 $4,735 $3,845 $2,805
Four Color
FREQUENCY KING-PG 3/4-PG ISLAND 1/2-PG 1/4-PG
1 × $8,335 $7,905 $7,005 $5,605
6 × $8,275 $7,870 $6,960 $5,585
12 × $8,225 $7,825 $6,925 $5,555
24 × $8,160 $7,780 $6,880 $5,540
36 × $8,105 $7,745 $6,835 $5,525
48 × $8,045 $7,705 $6,795 $5,510
60 × $8,010 $7,665 $6,765 $5,480
72 × $7,965 $7,620 $6,720 $5,460
96 × $7,940 $7,580 $6,670 $5,445
120 × $7,900 $7,540 $6,640 $5,415
144 × $7,865 $7,495 $6,590 $5,400
170 × $7,815 $7,460 $6,545 $5,380
194 × $7,775 $7,420 $6,515 $5,355
216 × $7,740 $7,370 $6,480 $5,340
242 × $7,690 $7,335 $6,430 $5,325
268 × $7,660 $7,300 $6,395 $5,300
304 × $7,610 $7,250 $6,350 $5,280
340 × $7,535 $7,175 $6,270 $5,230
376 × $7,485 $7,125 $6,235 $5,195
All published rates are in USD
5
2019 R
ate
Ca
rd •
The
ASC
O P
ost
Print Advertising Rates
KING PAGESPREAD
KING PAGE
3/4 PAGE
ISLAND PAGE HALF PAGE
HORIZONTAL
HALF PAGE
VERTICAL
1/4PAGEVERT
1/4 PAGE RECTANGLE
ISLAND PAGE
SPREAD
COLOR CHARGES
Four color $2,390
Two color standard $800
Two color matched $1,155
Metallic $1,430
Four color + metallic $3,820
Five color $3,545
Bleed: No charge
PREMIUM POSITION CHARGES
Fourth cover 50% over B&W rate
Third cover 15% over B&W rate
First ad 25% over B&W rate
Center spread 25% over B&W rate
Consecutive right-hand pages 20%* over B&W rate
All other guaranteed positioning 10% over B&W rate
*On 2nd and 3rd pages, up to 3 pages. For addt'l pages contact Publisher.
Net Rates Cover Tips Supplied With PI Attached and WithoutFREQUENCY 2 PG SUPPLIED 2 PG PLUS PI
1 × $29,865 $35,865
6 × $29,595 $35,595
12 × $29,385 $35,385
24 × $29,115 $35,115
36 × $28,845 $34,845
48 × $28,605 $34,605
60 × $28,425 $34,425
72 × $28,155 $34,155
96 × $27,855 $33,855
120 × $27,675 $33,675
144 × $27,375 $33,375
170 × $27,105 $33,105
194 × $26,925 $32,925
216 × $26,715 $32,715
242 × $26,415 $32,415
268 × $26,205 $32,205
304 × $25,935 $31,935
340 × $25,455 $31,455
376 × $25,245 $31,245
Meeting Listing Rates and Specs for Meeting PlannersAdvertisements available in oncology meeting section.
NET PRICING 1 × 3 × 6 ×
1/4 pg 4c $3,850 $3,655 $3,470
1/8 pg 4c $2,785 $2,625 $2,470
6
201
9 R
ate
Ca
rd •
Th
e A
SCO
Po
st Print Advertising Rates Acceptance of AdvertisingAll advertising is subject to approval of the Editor-in-Chief, publisher, and ASCO. New advertisements are to be received by the publisher at least two weeks before the closing date. Please email all ad proofs to Norman W. Virtue at [email protected]. The publisher reserves the right to label any advertisement as such for any ads that contain significant editorial content or that look like editorial pages.
The advertiser and advertising agency accept and assume liability for all content (including text, representations, illustrations, opinions, and facts) of advertisements and their compliance with all applicable laws and regulations and also assume responsibility for any claims made against the publisher or ASCO arising from or related to such advertisements.
Advertiser and advertising agency recognize and accept that the following language appears within the publication: “All statements, including product claims, are those of the person or organization making the statement or claim. Neither the publisher nor ASCO adopts any such statement or claim as its own, and any such statement or claim does not necessarily reflect the opinion of the publisher or ASCO.”
In the event that legal action or a claim is made against the publisher or ASCO arising from or related to such advertisements, the advertiser and advertising agency agree to fully defend, indemnify, and hold harmless the publisher and ASCO and to pay any judgment, expenses, and legal fees incurred by the publisher or ASCO as a result of said legal action or claim.
In addition, the publisher reserves the right to reject or discontinue any advertising for any reason. This right shall not be deemed to have been waived by acceptance or actual use of any advertising matter.
The publisher reserves the right to label any advertisement as such for any ads that contain significant editorial content or that look like text pages. The publisher is not liable for delays in delivery and/or nondelivery due to any condition beyond the control of the publisher affecting production or delivery in any manner.
The publisher reserves the right to reject any advertising that it believes is not in keeping with the publication’s standards.
Advertiser and advertising agency agree to indemnify, defend, and hold harmless the publisher from any and all liability for content (including text, illustrations, representatives, sketches, maps, trademarks, labels, or other copyrighted matter) of advertisement printed or the unauthorized use of any person’s name or photography arising from the publisher’s reproduction and publishing of such advertisements pursuant to the advertiser’s or agency’s order.
Insert Conversion Program — For Multipage Insert Advertisers OnlyHarborside can convert inserts of 4 pages or larger to king-sized ad pages at no cost. The converted ad will be billed at the king-sized B&W page rate times the number of pages. Digital file required. For additional information, please contact Norman W. Virtue at 631-935-7682 or [email protected].
Business Reply Card (BRC) InsertsBRCs are billed at half of a 2-page island-sized insert rate page with a minimum island half-page ad opposite. A sample of the BRC and paper must be submitted to the publisher for approval two weeks before closing date.
List Match ChargeHarborside will match any client list to The ASCO Post's circulation. The first 2 list matches are free, charge of $2,000 applies to all subsequent matches. If the client chooses to advertise to the selected audience through a demo insert, the appropriate demo charge will apply, and the initial list match fee will be waived. Maximum of 2 list matches per year per brand.
Split-Run Inserts Production ChargeBilling is based on the earned insert rate times the percentage of circulation, with a minimum of 50% of the total circulation, plus a noncommissionable production charge of $2,000. For a run-of-book split-run charge, please contact the publisher.Note: there is a maximum of 4 split-runs per issue
Earned FrequencyEarned Frequency: Harborside will determine the number of pages and fractions of pages placed in The ASCO Post during the year.
Combined Frequency: Harborside will combine all advertising insertions of a parent company and its subsidiaries to determine the earned rate.
ServicesA) ReprintsReprints are available for order. Contact Gail van Koot at [email protected].
B) Availability of ASCO Mailing ListContact Infocus Marketing Inc. List Manager, 4245 Sigler Road, Warrenton, VA 20187; 540-428-3251; or www.infocusnet.com
C) Sponsorship Opportunities AvailableSupplements, special issues, newsletters, patient education material, and additional customized opportunities available. Contact David Horowitz at 631-935-7652 or [email protected]
Agency DiscountsFifteen percent (15%) of gross billings on space, color, cover, and preferred position charges. Additional production charges are noncommissionable.
7
2019 R
ate
Ca
rd •
The
ASC
O P
ost
Print Advertising Rates & SpecificationsDiscounts and IncentivesEarned Frequency Combination Discount Advertisers in ASCO Publications: The ASCO Post, Journal of Clinical Oncology (JCO), and Journal of Oncology Practice (JOP) combine for pages to earn the frequency rate in The ASCO Post as well as in all the ASCO publications.Space purchased by a parent company and subsidiaries is combined in calculating the earned rate. When the number of insertions is greater or less than indicated by the contract, rates are adjusted accordingly. Please contact the publisher for details. Frequency will be determined by the total number of pages placed in these publications during a calendar year.
Two Publication DiscountEach individual product advertising in ASCO’s Journal of Clinical Oncology (JCO) OR ASCO’s Journal of Oncology Practice (JOP) during the same month it advertises in The ASCO Post will receive a $500 per page discount in The ASCO Post and either a $200 discount in JCO or a $350 discount in JOP. Discount is based on the matching number of pages in The ASCO Post and JCO or JOP in a given month.
Total savings:
The ASCO Post + JCO = $700The ASCO Post + JOP = $850
Three Publication DiscountEach individual product advertising in ASCO’s Journal of Clinical Oncology (JCO) AND ASCO’s Journal of Oncology Practice (JOP) during the same month it advertises in The ASCO Post will receive a $500 per page discount in The ASCO Post and a $250 discount in JCO and a $400 discount in JOP. Discount is based on the matching number of pages in The ASCO Post and JCO and JOP in a given month.
Total savings:
JOP + JCO + The ASCO Post = $1,150
Continuity ProgramEach individual brand advertising in: 6 issues will receive 1 free ad, 10 issues will receive 2 free ads, 15 issues will receive 3 free ads, 20 issues will receive 4 free ads, of the same size for the brand. Free ad is based on smallest size ad run. If multiple sized ad units are placed in issues within a calendar year, the free ad unit will be determined by the average dollar amount spent per issue over the course of the year. This amount will be credited towards the last insertion of the year.
Large PI DiscountAdvertise three or more prescribing information (PI) pages for a single ad for a brand and receive a 50% discount on the B&W page rate beginning on the third PI page. The Multi-journal discount is not eligible on discounted PI pages.
Requirements for Cover Tips, Inserts or Outserts2 mockups must be provided for proposed piece. Mockups are needed to head off potential problems during binding and allow Publisher to provide feedback on how to correct any problems prior to delivery. Once samples are received, it will also be determined if additional postage and binding charges will be necessary. For a simple two-sided piece, a mockup is not necessary. All other configurations require mockups, which are due 4 weeks before due date to printer.
Send samples to: Norman Virtue, Harborside, 94 North Woodhull Road, Huntington, NY 11743. Send PDF file of the creative for preapproval by ASCO to: [email protected]
Once Approved Ship printed pieces: Tammy Baugh, LSC Communications 13487 South Preston Highway Lebanon Junction, KY 40150Material must be shipped in cartons. Material needs to be cross stacked in cartons. Please note that the use of shrink wrapping or additional binding will incur additional costs.Cartons must indicate publication name, issue date, and quantity.
Cover Tip Specifications:• Quantity: 32,700• Standard 2 page (front and back)• Maximum trim size: 10.25" wide × 6" high • Minimum trim size: 6" wide × 4" high• Minimum paper weight: 70#• Cover tip should be supplied trimmed. Tip will be flush (with
variation of up to 0.125") to spine and foot of cover.• Two samples are required for preapproval and evaluation,
along with a PDF of the file for ASCO approval.The ASCO Post accepts cover tip variations–cover tip with PI affixed to back, pocket cover tips with PI enclosed, etc. It is recommended that there be 2" clearance between the edge of the PI and the gutter edge of the cover tip.
Insert Specifications:• Quantity: 32,700• Paper weight: 80# - 100# text• Dimensions: A-size 8" × 11" pretrimmed. Inserts should be
supplied folded.• Inserts are tipped in to the publication flush to the gutter
and foot. • Saddle-stitched inserts are available at an extra cost. Such
inserts require a 4.5" hanger. • Two samples are required for preapproval and evaluation,
along with a PDF of the file for ASCO approval.
Outsert Specifications:• Quantity: 32,700• Outserts must be supplied as single units. They cannot be
supplied individually shrink wrapped. Any PI information must be spot glued inside the Outsert.
• Dimensions: Outserts are limited to the size of the host publication 10.5" × 14". Two samples are required for preapproval and evaluation.
Please submit a PDF of the creative for preapproval by ASCO and publisher.
8
201
9 R
ate
Ca
rd •
Th
e A
SCO
Po
st Print Specifications & Closing Dates
File SubmissionsSWOP standards apply. Submit only high-resolution CMYK PDF formatted files. Convert all spot colors to CMYK. All fonts and images must be embedded. Files should indicate trim and bleed.
Contact the Production Manager at [email protected] for additional specifications and production questions.
Please see examples of ad sizes and placements on page 5
Material Storage
Files are held for one year and then destroyed, unless instructed otherwise in writing. Unused inserts will be destroyed one month after issue mails.
Insertion Order Submisionsemail: [email protected] Insertion order should include an ad code or unique identifier to help properly identify the corresponding ad material.
Ad Materials to: email: [email protected] FTP: ftp.harborsidenexus.com Username: hspsales password: Connect!1
Color Proofs to: Norman W. Virtue, The ASCO Post, Harborside 94 North Woodhull Road, Huntington, NY 11743 Tel: 631-935-7682, Fax: 631-692-0805
Closing DatesISSUE DATE
INSERTION ORDER DUE
AD MATERIAL DUE
INSERTS DUE
Jan 25th 12/21/18 1/2/19 1/9/19
Feb 10th 1/10/19 1/17/19 1/24/19
Feb 25th 1/24/19 1/31/19 2/7/19
Mar 10th 2/8/19 2/14/19 2/21/19
Mar 25th 2/21/19 2/28/19 3/7/19
Apr 10th 3/7/19 3/14/19 3/21/19
Apr 25th 3/21/19 3/28/19 4/4/19
May 10th 4/8/19 4/15/19 4/22/19
May 25th 4/23/19 4/30/19 5/7/19
Jun 3rd* 4/26/19 5/3/19 5/10/19
Jun 10th 5/9/19 5/16/19 5/23/19
Jun 25th 5/23/19 5/30/19 6/6/19
Jul 10th 6/10/19 6/17/19 6/24/19
Jul 25th 6/26/19 7/3/19 7/10/19
Aug 10th 7/11/19 7/18/19 7/25/19
Aug 25th 7/25/19 8/1/19 8/8/19
Sep 10th 8/8/19 8/15/19 8/22/19
Sep 25th 8/22/19 8/29/19 9/5/19
Oct 10th 9/9/19 9/16/19 9/23/19
Oct 25th 9/25/19 10/2/19 10/9/19
Nov 10th 10/10/19 10/17/19 10/24/19
Nov 25th 10/24/19 10/31/19 11/7/19
Dec 10th 11/7/19 11/14/19 11/21/19
Dec 25th 11/21/19 11/28/19 12/5/19
9
2019 R
ate
Ca
rd •
The
ASC
O P
ost
The ASCO Post Meetings Coverage and Issue Dates, 2019
ISSUE DATE NEWS COVERAGE (TENTATIVE) BONUS DISTRIBUTION AT*
Jan 25th
American Society of Hematology (ASH), San Antonio Breast Cancer Symposium SABCS), American Society for Therapeutic Radiology (ASTRO), European Society for Medical Oncology (ESMO), Palliative and Supportive Care in Cancer, NCCN Policy Summit: Equity in Cancer Care, ESMO Immuno-Oncology Congress, International Society for Geriatric Oncology (SIOG) Annual Meeting; Annual Meeting of the Society of Urologic Oncology (SUO)
Genitourinary Cancers Symposium
Feb 10th ASH, SABCS, ASTRO, ESMO, Adolescent and Young Adult (AYA) Cancer Congress, World Cancer Congress ASCO SITC
Feb 25th Gastrointestinal Cancers Symposium (GI Symposium), American Association for Clinical Research Conference on Melanoma (AACR), ASH, SABCS, World Cancer Congress
Mar 10th GI Cancers Symposium, Genitourinary Cancers Symposium (GU Symposium)NCCN Annual Conference;
Society of Surgical Oncology
Mar 25th ASCO-SITC Clinical Immuno-Oncology Symposium, GI Cancers Symposium, GU Cancers Symposium
ONS Oncology Nurse Symposium
Apr 10thGU Cancers Symposium, Miami Breast Cancer Conference, Multidisciplinary Thoracic Cancers Symposium, Society of Gynecologic Oncology Annual Meeting (SGO), St. Gallen International Breast Cancer Conference, NCCN Annual Conference
Apr 25thSociety of Surgical Oncology (SSO) Annual Meeting, NCCN Annual Conference, St. Gallen International Breast Cancer Conference, SGO, Miami Breast Cancer Conference, Annual Symposium on Pancreatic Cancer
May 10thImmunotherapy of Cancer Conference, European Lung Cancer Congress, SSO Annual Meeting, SGO Annual Meeting, European Kidney Cancer Association International Meeting, Community Oncology Alliance (COA)
May 25th AACR Annual Meeting, SSO Annual Meeting, Oncology Nursing Society Annual Congress (ONS), SGO Annual Meeting, ASCO 2019 Pre-Meeting Highlights, COA 2019 ASCO Annual Meeting
Jun 3rd Narratives in Oncology 2019 ASCO Annual MeetingJun 10th ASCO Annual Meeting, AACR Annual Meeting, NCCN Annual ConferenceJun 25th ASCO Annual Meeting, AACR Annual Meeting, American Head & Neck Society Annual MeetingJul 10th ASCO Annual Meeting, International Conference on Malignant Lymphoma BOA Austin and SeattleJul 25th ASCO Annual Meeting, MASCC/ISOO Annual Meeting on Supportive Care in Cancer BOA Baltimore
Aug 10th Best of ASCO, Seattle, ASCO Annual Meeting, MASCC/ISOO, International Conference on Malignant Lymphoma
Aug 25th Best of ASCO, Austin, MASCC/ISOO, International Conference on Malignant Lymphoma ASCO Quality Care
Sep 10th Best of ASCO, Seattle, Best of ASCO, Austin, Best of ASCO, BaltimoreNCCN Hem Malignancies;
American Society of Radiation Oncology (ASTRO)
Sep 25th Best of ASCO, Baltimore, MASCC/ISOO
Oct 10th NCCN Hematologic Malignancies Congress, IASLC World Conference on Lung Cancer, Debates and Didactics in Hem/Onc JADPRO Live
Oct 25th IASLC World Lung Cancer Congress, Society of Hematology-Oncology (SOHO), International Workshop on Chronic Lymphocytic Leukemia (IwCLL)
Nov 10th Quality Care Congress, ESMO, IASLC World Lung Cancer Congress
Nov 25th Quality Cancer Congress, ESMO, IASLC World Lung Cancer Congress, ASTRO Annual Meeting, SOHO, IwCLL, Society of Integrative Oncology (SIO) Annual Meeting ASH Annual Meeting, SABCS
Dec 10th ASTRO Annual Meeting, ESMO, JADPROLive, Palliative Care in Oncology, Chemotherapy Foundation Symposium
Dec 25th ASH, Palliative Care in Oncology, Society for NeuroOncology Annual Meeting, Annual Meeting of the Society of Urologic Oncology (SUO), SITC 34th Annual Conference
2020 Gastrointestinal Cancers Symposium
*Subject to change
10
201
9 R
ate
Ca
rd •
Th
e A
SCO
Po
st Digital Advertising OpportunitiesASCOPost.comASCOPost.com is home to the full-text from the current issue of The ASCO Post and complete archives of past issues. The “Today in Oncology” section, located on the home page of ASCOPost.com, is a newsfeed updated daily with original news reports of meeting abstracts and recently published peer-reviewed literature. Further, The ASCO Post Newsreels is video program including coverage from major oncology meetings and interviews with thought-leaders throughout the field. ASCOPost.com is fully searchable by topic or keyword. The website allows for social media options in addition to its daily oncology news feed.
Ad Sizes Available• Leaderboard: 728 × 90*• Medium Rectangle: 300 × 250• Mobile Leaderboard: 320 × 50*On mobile size displays the 728 x 90 ad location
is replaced with a 320 x 50 banner ad.
RatesROS: $225 CPM rate
Discounts• 5% for print advertiser• 5% for 6+ month advertiser
Geotargeting available at a 10% premium
NEW in 2019–Affinity targeting on ascopost.com$275-$325 CPM rates for high affinity readers of specific targeted content: Lung, Breast, GI Cancers, GU cancers, Hem Cancers. Contact Leslie Dubin regarding availability.
FeedbackASCOPost.com 2018 Average Stats*
Sessions Per Month 134,251
New Users Per Month 81,782
Pages Per Month 181,238
Pages Per Session 1.35
Time on Site 1:14
Impressions Per Month 571,606
CTR 0.13%
*Based on U.S. average stats Jan-Jun 2018, Google Analytics, Google DFP and MOAT Analytics.
ASCOPost.com 2018 Average Stats* GLOBAL
Sessions Per Month 233,908
New Users Per Month 138,182
Pages Per Session 1.34
Time on Site 1:17
*Based on Global average stats Jan-Jun 2018, Google Analytics, Google DFP and MOAT Analytics.
Article Page
Smart Phone
Tablet
Desktop
Article Page
Article Page
Home Page
Home Page
Home Page
320x 50
320x 50
728 X 90 728 X 90
728 X 90
300 X 250
728 X 90
300 X 250
300 X 250
300 X 250
11
2019 R
ate
Ca
rd •
The
ASC
O P
ost
Digital Advertising OpportunitiesThe ASCO Post Evening NewsThe ASCO Post Evening News is an original newsletter distributed via email on weekday evenings to more than 34,000 oncology professionals, including all ASCO members. The newsletter features original reporting of news from professional meetings, conferences, educational programs, and peer-reviewed scientific journals, as well as summaries of recent oncology news featured on The ASCO Post website and highlights from the Newsreels video series. The ASCO Post Evening News was developed by Harborside Press in collaboration with ASCO.
Trending InTrending In is a section in The ASCO Post Evening News that runs monthly and highlights the most read stories in particular topics of interest.
Circulation34,637 ASCO Members and other oncology professionals:• 22,868 US-based
» 21,313 US-based ASCO members and requesters » 1,555 Advanced Practitioners in oncology
Default is US only for advertisers. International targeted coverage is available, inquire for pricing.
(11,769 International ASCO members also receive)
Ads Available• Leaderboard Banner: 728 × 90• Wide Skyscraper: 160 × 600• Medium Rectangle: 300 × 250• Larger sizes also may be available to accommodate ISIs
Schedule – Daily 215 ×/year Commitments due ten days prior to deployment date. Ad materials due one week prior to deployment date.
Dates are subject to change.
Rates & Packages Base price: $3,300 per ad
Discounts and free ads when bought in packages:• Buy 5 get 1 free, totals:
6 ads–1 × /every other month package: $16,500 net• Buy 10 get 2 free, totals:
Benefits• Consistency of ad message and increased frequency• Ability for clicks/links• Max of five ads per issue so high SOV
Feedback2018 Average Stats*
Open Rate 24.50% average
Unique Click Through Rate 5.46%
Delivery Rate 99.75%
*Based on U.S. average stats Jan-Jun 2018
12
201
9 R
ate
Ca
rd •
Th
e A
SCO
Po
st
E-TOC – The ASCO Post• 6-8 articles from each issue will be highlighted in the Electronic
Table of Contents (E-TOC)• Short summary with a direct link to the article on ASCOPost.com
as well as to homepage included• Delivers approximately one week before issue is received
Circulation32,440 ASCO Members and other Oncology professionals, including:• 21,060 US-based ASCO members and requesters• 11,380 International ASCO members
Default is US only for advertisers. International targeted coverage is available, inquire for pricing.
Ads Available• Leaderboard Banner: 728 × 90 or 468 × 60• Medium Rectangle: 300 × 250
Rates*• $2,995 net for Leaderboard Banner and Upper Medium Rectangle• $2,205 for the Lower Medium Rectangle*U.S. Only
The ASCO Post Almanacs & The ASCO Post Meeting Highlights
PRICING FOR ALMANACS AND MEETING HIGHLIGHTS
PACKAGE PRICE eTOCS WEBSITE COST
SOV #1 Cover Tip + TOC 50% SOV on Email #1 + Email #2 50% of impressions $60,000 net
SOV #2 Cover 2 + Cover 4 50% SOV on Email #1 + Email #2 50% of impressions $60,000 net
New opportunities to enhance reach to targeted audiences
The ASCO Post AlmanacsA round-up issue with news items specific to a disease site and/or tumor type. The ASCO Post Almanac is distributed via mail and email to a self-identified target audience plus Med Onc and/or Hem Onc readers of The ASCO Post.
Advertising Package: 50% SOV includes print and digital components.
The Almanacs are special editions of The ASCO Post.
• Review of the year's news in a specific area of cancer, with a look at what's on the horizon• Guest editor provides commentary on the current state of care and the most up-to-date info• Topic areas available* include:
» Breast cancer » CNS malignancies » Gastrointestinal cancers
» Genitourinary cancers » Gynecologic cancers » Head & neck cancer
» Hematologic malignancies » Lung cancer » Supportive care
» Melanoma/skin cancer » Sarcoma » Prostate cancer
*Topics are representative. Additional subject areas are available. Contact [email protected]
Almanacs - contact Leslie Dubin at [email protected] for specific circulations/opportunities.
The ASCO Post Meeting HighlightsMeeting Highlights are special editions of The ASCO Post
PRINT DIGITAL WEBSITE
CONFERENCE SPECIALTY AUDIENCE
PRINT CIRCULATION eTOC #1 eTOC #2 IMPRESSIONS
Gastrointestinal Cancers Symposium
GI 6,276 22,868 1,770 500-1,500
ASCO-SITC Immuno Onc Symposium
Med Oncs plus Hem Oncs 14,400 22,868 8,400 500-1,500
Genitourinary Cancers Symposium
GU 5,700 22,868 1,122 500-1,500
Thoracic Cancers Symposium
Lung 7,600 22,868 2,180 500-1,500
ASCO Annual Meeting Med Oncs plus Hem Oncs 28,068 22,868 8,300 500-1,500
ESMO Med Oncs plus Hem Oncs 14,400 22,868 8,300 500-1,500
San Antonio Breast Cancer Symposium
Breast Cancer 8,000 22,868 3,455 500-1,500
American Society of Hematology
Hematology 14,300 22,868 4,042 500-1,500
Note: Bonus distribution (approx 300 copies) may be available at other meetings of interest.
• Highlights from important meetings of interest• These issues are A-sized (not tabloid)
• Guest editor to offer perspective and relevance to practicing oncologists• Ad specs available upon request
14
201
9 R
ate
Ca
rd •
Th
e A
SCO
Po
st
SPECIFICATION WEBSITE E-TOC/THE ASCO POST EVENING NEWS
Ad expansion sizesLeaderboard (728 × 315)Medium rectangle (600 × 250)
N/A
Ad expansion notesAd must require user initiation before expansion. Expanded ad must include clearly visible close controls.
N/A
Ad formats JPG, GIF, HTML5, third-party served ads JPG, GIF, animated GIF
Maximum initial file load size 200K 100K
Rich media file size 200K N/A
Animation time 15 seconds/3 loops 15 seconds/3 loops**
Border All ads with white or partially white background must use a 1 pixel dark colored border
All ads with white or partially white background must use a 1 pixel dark colored border
Third-party click and pixel tracking available† By request By request
Alternate text required‡ Yes Yes
Maximum Ad Resource Requests*** 15 N/A
All ad creative is subject to approval from the American Society of Clinical Oncology. For times when the user’s browser does not support creative functionality (i.e. Flash™, HTML5), provide a standard image file.
**Please ensure that the first frame of the animated GIF makes sense as a static image.
*** Resource request limits include any tracking scripts that the agency/advertiser may be utilizing in conjunction with their campaign.
‡Please provide alternative text (up to 64 characters including spaces).
Interactive ads will allow for unlimited file load after user-initiated interaction. User initiation is the willful act of a user to engage with an ad. Users may interact by clicking on the ad.
File weight calculation: All files for the ad, including supporting files and agency supplied tracking scripts, must be included as part of the maximum file weight calculation for all file limits load.
HTML5 Best Practice Notes
HTML5 ads are like mini web pages. You can improve initial display by following a few guidelines:
• Provide inline css and use HTML to deliver initial display resources as much as possible.
• Limit initial dependencies on any render-blocking .js or .css• Load interactive elements as a deferred or secondary subload, but keep them
efficient using techniques such as caching.• Defer heavy file weights until user initiates interaction.• Use techniques such as byte-serving to download partial content and to
optimize for auto-play video.• Avoid any unnecessary downloads.• Combine all supporting files e.g., JavaScript toolkits, libraries, HTML and CSS
whenever possible.
Ads must not load more than 15 supporting files, including any agency supplied tracking scripts.
Use well-distributed, cached libraries to provide supporting files instead of providing them with the ad.
Check device and bandwidth and tailor supporting files and other elements to the environment and experience.
Harborside utilizes MOAT analytics for comprehensive data on advertising viewability. If there is a 10% difference between third-party reporting, a conversation ensues between client and Harborside.
†No Advertising shall include any pixels, tags, Flash containers or any other type of information collection software code (i.e. any such pixel, tag, code or device commonly referred to as a “Pixel”), nor place any beacons, cookies or other information collection devices on the browsers of users unless expressly approved in writing by Harborside. If Harboside approves the inclusion of a Pixel in an advertisement, then unless and only to the extent that such approval contains an express exception, (i) Advertiser may not use such Pixel to collect any personally-identifiable information (PII) with respect to any ASCO Post user, (ii) no such Pixel can be flash or object based, (iii) No cookies may be placed on a user’s system, (iv) Advertiser will not link any non-PII that it collects to any PII that it may have from any other source and (v) Advertiser will not update any existing profile or create any profile in its database based on any data collected on the ASCO Post site, including the fact that someone is a ASCO Post user or any information derived from the information in the referring URL.
We cannot honor viewability related campaign goals if ads are supplied that do not meet the specifications supplied in the grid above.
NHT related campaign requirements cannot be honored if logs including IP addresses and timestamps are not supplied of suspected NHT generated impressions for verification. These logs also enable us to ensure that we filter out future NHT visitations from these addresses if deemed valid. Harborside will supply a report back of any NHT traffic deemed valid along with supporting evidence.
Digital Specifications
All ad creative is due one week prior to live date and is subject to approval by ASCO. HTML5 ads must be provided as soon as possible for testing purposes.
15
2019 R
ate
Ca
rd •
The
ASC
O P
ost
The publisher is not liable for delays in delivery and/or nondelivery in the event of Act of God, action by any governmental or quasigovernmental entity, fire, flood, insurrection, riot, explosion, embargo, strikes (whether legal or illegal), labor or material shortage, transportation interruption of any kind, work slow-down, or any condition beyond the control of the publisher affecting production or delivery in any manner.
Insertion Order and Copy Regulations: Insertion instructions shall be supplied for every advertisement and shall clearly state the following information: name of publication, name of advertiser, date to be inserted, size of advertisement, identification of advertisement (proof of ad to be furnished if possible), plus any special instruction such as bleed and color.
Cancellation of space order forfeits the right to position protection.
The publisher’s liability for any error will not exceed the charge for the advertisement in question.
The publisher assumes no liability if for any reason it becomes necessary to omit an advertisement.
When change of copy, covered by an uncancelled insertion order, is not received by the closing date, copy run in the previous issue will be inserted.
Requests for specified position at ROB rates are given consideration, but no guarantee is made unless the position premium has been agreed to in the contract.
The publisher reserves the right to hold advertiser and/or its advertising agency jointly and severally liable for such monies as are due and payable to the publisher.
In the event that an advertiser is owed a credit as a result of adjustment of frequency rates, the publisher will provide credit only on future advertisements.
Payment Terms: Net 30 days of invoice date. Pre-payment discounts are available, contact publisher for more details.
Payment for New Advertisers: All new advertisers are required to prepay until credit and/or reference checks are completed. Once approved, Harborside payment terms are net 30 days. Contact Leslie Dubin ([email protected]) for more details.
Viewability: 70% Viewability is current industry standard. Ads taking more than 3 seconds to load will not qualify for viewability makegoods. Harborside utilizes MOAT analytics for comprehensive data on advertising viewabilty. If there is a 10% difference between third-party reporting, a conversation ensues between client and Harborside.
Cancellation Policies Print Cancellations: Cancellations in advertising by the advertiser or its agency may not be made after the closing date for the publication unless otherwise agreed to by both parties in writing.
Premium Position, Cover Tip, and Outsert Cancellations: Must be prior to 60 days of the published closing date. After the published closing date, any cover-tip is non-cancelable, and full payment is due. Please see page 5 for list of premium positions.
Digital Cancellations for e-TOC’s and Evening News: In accordance with the AAAA/IAB Standard Terms and Conditions for Internet Advertising Version 3.0) found at https://www.iab.com/wp-content/uploads/2015/06/IAB_4As-tsandcs-FINAL.pdf Advertiser may cancel the I/O as follows:
For Flat-Fee or Fixed Placements (e-TOC’s and Evening News)
• With minimum of 30 days prior written notice: no penalty
• With less than 30 days prior written notice: Advertiser is responsible for any contracted media to be served within 30 days
• NHT and Viewability Campaign requirements will not be honored on Flat-Fee (SOV) or Fixed Placements
Website: Advertiser may cancel the entire IO, or any portion thereof of a CPM buy, as follows: 14 days’ prior written notice from advertiser without penalty. However, for a yearly buy, advertiser can cancel twice with 14 days notice. All ensuing cancellations will require 30 days prior notice to avoid penalty charge.
